GN2484 | Action Medical Research


Neurofibromatosis type 2: finding new treatments for young people with this rare and disabling disease

Research date: 1 September 2016 - 31 August 2018
Grant amount: £65,061.00

Around one in 35,000 people has a rare genetic illness called neurofibromatosis type two (NF2), which tends to be diagnosed during childhood and early adulthood.1 People with NF2 develop multiple benign tumours in the nervous system. Although they’re not cancerous, these tumours can cause distressing symptoms including hearing loss, speech...

Other related information

Fighting a condition that causes multiple tumours

Posted: 27 March 2017 13:55 pm
Neurofibromatosis type two causes tumours to develop in the nervous system, typically in the brain and spine. Although not cancerous, these can cause devastating symptoms. Dr Sylwia Ammoun hopes to develop a much-needed new treatment for this rare genetic disease. Around 40 people, most of them teenagers or young adults, are diagnosed with...
Help us spread the word